New Platform Will Open Pharmacogenetics Door to Bioinformatics Company Compugen | GenomeWeb

Compugen wants to dip its toes into the pharmacogenomics pond.

Two years ago, the Israeli bioinformatics company began laying the groundwork for a vast and comprehensive data repository it hopes drug makers will find irresistible. This summer, Compugen plans to commercialize it as a service that ties together an array of clinical data from millions of patients that biopharmas can use to improve drug-development protocols.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.